Nevertheless, neo-angiogenesis, dysfunctional tumor vasculature, increased interstitial fluid pressure, and efflux pumps, namely P-glycoprotein (P-gp), hinder intracellular therapeutic concentrations of cytotoxic drugs reaching the tumor site. The gene discussed is ABCB1; the disease is neoplasm.